A cross-disciplinary panel bringing together leaders working across the most advanced and emerging applications of LNP delivery, including srRNA, gene editing, in vivo cell therapy, oncology, autoimmune disease and protein replacement.

• Compare delivery requirements across different therapeutic modalities
• Identify where LNPs are already working vs where they are still failing
• Understand how application choice impacts design, toxicity and manufacturability
• Evaluate which areas are overhyped vs commercially viable
• Explore how hybrid systems (lipids, polymers, peptides) are expanding capability